Skip to main content

Table 2 Predictors of micronutrient level in visceral leishmaniasis patients (n = 1309)

From: Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Dependent Variables

Predictors

β [95% CI β]

P-value

Serum zinc level

Problematic alcohol use

-2.7[−4.01 - -1.5]

< 0.01

Female sex

-1.28 [−2.5 - -0.07]

0.04

DDS

9.75 [7.71–11.79]

< 0.01

High family size

−1.63 [−2.68 - -0.58]

< 0.01

HIV

−2.95 [−4.97 - -0.92]

< 0.01

Age

−0.043 [−0.08 - -0.01]

0.01

Anti-leishmaniasis treatments

0.09 [−0.3–0.48]

0.66

Iron

Alcohol

7.6 [5.86–9.35]

< 0.01

Chronic diseases

−7.44 [−9.75 - -5.13]

0.01

Malaria

−12.69 [−14.53 - -10.87]

< 0.01

Hookworm

−4.48 [−6.82 - -2.14]

< 0.01

High family size

−5.14 [−7.01 - -3.28]

< 0.01

HIV

−5.51 [−8.23 - -2.78]

< 0.01

Age

0.11 [0.07–0.15]

< 0.01

MUAC

0.75 [0.21–1.29]

< 0.01

Anti-leishmaniasis treatments

0.67 [0.08–1.27]

0.02

Serum Selenium

HIV

−18.1 [−20.63 - -15.58]

< 0.01

High family size

−11.36 [− 13.02 - -9.7]

< 0.01

Anti-leishmaniasis treatments

3.04 [2.32–3.76]

< 0.01

Iodine

Malaria

−3.78 [−6.16 - -1.39]

< 0.01

DDS

25 .84 [22.57–29.1]

< 0.01

Smoking

−12.34 [− 15.98 - -8.7]

< 0.01

HIV

−38.02 [−41.98 - -34.06]

< 0.01

Chronic illness

−5.14 [−7.82 - -2.46]

< 0.01

Regular physical exercise

5.82 [0.39–11.26]

0.04

Anti-leishmaniasis treatments

13.67 [13.15–14.2]

< 0.01

Vitamin A

Problematic alcohol use

−1.09 [− 2.01 - -0.17]

0.02

Chronic illness

−2.56 [−3.53 - -1.59]

< 0.01

Urban residence

0.81 [0.08–1.54]

0.03

DDS

1.62 [0.36–2.88]

0.01

Malaria

−4.8 [−5.91 - -3.85]

< 0.01

High family size

−5.03 [− 5.83 - -4.22]

< 0.01

HIV

−2.89 [−4.44 - -1.34]

< 0.01

Age

0.09 [0.07–0.12]

< 0.01

MUAC

0.86 [0.52–1.21]

< 0.01

Anti-leishmaniasis treatments

−0.3 [− 0.62 - -0.17]

0.06

Vitamin D

BMI

1.52 [0.42–2.6]

< 0.01

DDS

16.24 [14.89–17.58]

< 0.01

Malaria

−0.61 [−3.37 - -3.37]

< 0.01

Hookworm

−3.94 [−5.46 - -2.41]

< 0.01

High family size

−1.15 [−2.03 - -0.28]

< 0.01

HIV

−9.43 [− 10.92 - -7.94]

< 0.01

Age

0.03 [0.001–0.06]

0.04

Anti-leishmaniasis treatments

−0.94 [−1.25 - -0.63]

< 0.01